Amrion explores sale of company; revenues climb 31% in third quarter.
This article was originally published in The Tan Sheet
Executive Summary
AMRION SEEKING POTENTIAL BUYER OR "BUSINESS COMBINATION" with the help of The Wallach Company, a Denver-based financial advisor/investment banker, the dietary supplement firm announced on Oct. 16. "No such transactions are currently pending as the financial advisor is conducting its process," Amrion CEO Mark Crossen stated, noting that "the engagement of the Wallach Company will assist Amrion in its efforts to maximize shareholder value."